[Dasabuvir/ombitasvir/paritaprevir/ritonavir (Addendum to Commissions A15-03 and A15-04)]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003086
German
Original Title:
Dasabuvir Ombitasvir/Paritaprevir/Ritonavir (Addendum zu den Aufträgen A15-03 und A15-04)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a15-21.html
Year Published:
2015
URL for published report:
https://www.iqwig.de/download/A15-21_Addendum-zu-A15-03_A15-04_Dasabuvir_Ombitasvir-Paritaprevir-Ritonavir.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Hepatitis C, Chronic
- Ritonavir
- Antiviral Agents
- Hepatitis C
- Anilides
- Sulfonamides
- Cyclopropanes
- HIV Protease Inhibitors
Keywords
- Dasabuvir
- Ombitasvir
- Paritaprevir
- Ritonavir
- Hepatitis C - Chronic
- Benefit Assessment
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.